52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Berkshire Hathaway Inc Reports 27.8% Stake In Davita Inc
FTC Approves Final Order Imposing Conditions On UnitedHealth Group's Proposed Acquisition Of Davita Medical Group
Davita Announces New Senior Secured Credit Agreement
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.
2000 16th St
Kent J. Thiry
Executive Chairman of the Board
Javier J. Rodriguez
Chief Executive Officer, Director
Chief Financial Officer, Treasurer
James K. Hilger
Chief Accounting Officer
James O. Hearty
Chief Compliance Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Dialysis providers DaVita Inc and Fresenius Medical Care violated an anti-kickback law by contributing to a charity that helps kidney disease patients afford treatment that then steered business to them, a newly unsealed whistleblower lawsuit alleges.
UnitedHealth Group Inc won anti-trust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday.
UnitedHealth Group Inc won antitrust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday. (Reporting by Diane Bartz Editing by Leslie Adler)
DaVita Inc will pay $25.5 million to the families of three patients who won a $383.5 million jury verdict and who claimed their relatives suffered cardiac arrests and died soon after receiving dialysis treatments at the company's clinics.
A medical care unit of DaVita Inc <DVA.N> has agreed to pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.
A medical care unit of DaVita Inc will pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.
A federal jury in Colorado has awarded $383.5 million to the families of three patients who said they suffered cardiac arrests and died soon after receiving dialysis treatments at clinics run by DaVita Inc.
* BERKSHIRE HATHAWAY INC REPORTS 22.1 PERCENT STAKE IN DAVITA INC AS OF MAY 3, 2018 - SEC FILING
* Q1 EARNINGS PER SHARE VIEW $0.93 -- THOMSON REUTERS I/B/E/S
* DAVITA INC SAYS CEO KENT THIRY'S TOTAL 2017 COMPENSATION WAS $15.3 MILLION VERSUS $12.3 MILLION IN 2016
* Q4 ADJUSTED EARNINGS PER SHARE $0.92 FROM CONTINUING OPERATIONS
* DAVITA KIDNEY CARE ISSUES STATEMENT ABOUT DAVITA RX SETTLEMENT
A pharmacy services unit of DaVita Inc will pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements to patients, the U.S. Justice Department said.
A pharmacy services unit of DaVita Inc has agreed to pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements to patients, the U.S. Justice Department said.
The largest U.S. health insurer UnitedHealth Group Inc will buy DaVita Inc's primary and urgent care services for $4.9 billion in its second acquisition this year to expand its fast-growing medical group, it said on Wednesday.
The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:
UnitedHealth Group Inc said on Wednesday it would acquire kidney care services provider DaVita Inc's medical unit for about $4.9 billion in cash to expand its operations in ambulatory care services.
DaVita Inc <DVA.N>, the largest U.S. provider of kidney care services, is exploring a sale of its physician network business, DaVita Medical Group, that could value the unit at up to $4 billion, according to people familiar with the matter.
DaVita Inc <DVA.N>, the biggest U.S. dialysis services provider, swung to a third-quarter loss due to an impairment charge it took for the continued underperformance of its Medical Group healthcare delivery and management unit.
* Q3 earnings per share view $0.94 -- Thomson Reuters I/B/E/S
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.